Vol. 39 No. 4 (2022)

Published: 19-12-2022

  • Chylothorax associated with sarcoidosis: a review of the literature

    Lilach Israeli-Shani, Daniel King, Gali Epstein Shochet, David Shitrit, Ori Wand
    e2022039
    DOI: https://doi.org/10.36141/svdld.v39i4.12050

  • A case of hepatic and bone marrow sarcoidosis with progressive renal failure: diagnostic and therapeutic challenges

    Pierluigi Brugnaro, Francesca Cattelan, Erika Morelli, Andrea Petrucci, Alessandro Marocco, Sandro Panese, Pietro Maria Donisi, Giovanni Capitanio, Mauro Tollot
    e2022041
    DOI: https://doi.org/10.36141/svdld.v39i4.11350

  • Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy

    Kenan Yalta, Muhammet Gurdogan
    e2022036
    DOI: https://doi.org/10.36141/svdld.v39i4.13721
  • Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis

    Luigi Rizzi, Carlo Sabbà, Patrizia Suppressa
    e2022037
    DOI: https://doi.org/10.36141/svdld.v39i4.13372